Essex Bio-Technology sets 5 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend

Bulletin Express

07/24

Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong.

The agenda includes: 1. Reviewing and approving the interim financial results for the six months ended 30 June 2026. 2. Deliberating on the declaration and amount of any interim dividend.

The notice is signed by Director Fang Haizhou on behalf of the board. As of the announcement date (24 July 2026), the board comprises four executive directors—Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man—and three independent non-executive directors—Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1100299549"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100299549\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100299549?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-24 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100299549","market":"hk","top_or_hot":-1,"title":"Essex Bio-Technology sets 5 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend","media":"Bulletin Express","content":"<p>Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the interim financial results for the six months ended 30 June 2026.  \n2. Deliberating on the declaration and amount of any interim dividend.</p>\n<p>The notice is signed by Director Fang Haizhou on behalf of the board. As of the announcement date (24 July 2026), the board comprises four executive directors—Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man—and three independent non-executive directors—Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Essex Bio-Technology sets 5 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEssex Bio-Technology sets 5 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-24 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the interim financial results for the six months ended 30 June 2026.  \n2. Deliberating on the declaration and amount of any interim dividend.</p>\n<p>The notice is signed by Director Fang Haizhou on behalf of the board. As of the announcement date (24 July 2026), the board comprises four executive directors—Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man—and three independent non-executive directors—Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"","article_id":"1100299549","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100299549","pubTimestamp":1784883763,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01061":"亿胜生物科技"},"translate_title":"Essex Bio-Technology 定于 2026 年 8 月 5 日召开董事会会议，批准 2026 年上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong.\nThe agenda includes:  \n1. Reviewing and approving the interim financial results for the six months ended 30 June 2026.  \n2. Deliberating on the declaration and amount of any interim dividend.\nThe notice is signed by Director Fang Haizhou on behalf of the board. As of the announcement date (24 July 2026), the board comprises four executive directors—Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man—and three independent non-executive directors—Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}